About: Characterization of human complement receptor type 2 (CR2/CD21) as a receptor for IFN-alpha: a potential role in systemic lupus erythematosus

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Characterization of human complement receptor type 2 (CR2/CD21) as a receptor for IFN-alpha: a potential role in systemic lupus erythematosus Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 July 2006

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2006 (fr) наукова стаття, опублікована в липні 2006 (uk) im Juli 2006 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xunetu de 2006 (ast) scientific article published on 01 July 2006 (en)
publication date	wds:Q58428767-C54DAAEF-8812-4E79-B5E7-CBDA33733EE1
publication date	2006-07-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q58428767-F2BFC3FB-88BF-445F-824D-BC9FFA338431
language of work or name	English
author name string	wds:Q58428767-14A309AC-605C-4EE7-8A78-1200ADDA39CB wds:Q58428767-26C20F3B-67BE-4F06-9453-639377577337 wds:Q58428767-5942F504-9376-43B0-87B9-2DDBF742DA5D wds:Q58428767-98546E93-7294-4076-97AD-99A9D46255CF wds:Q58428767-AE9E111B-F70A-471E-B4FB-C0503B4E026D wds:Q58428767-E49D4A09-41F5-4AA2-BC01-26A245B50BA0 wds:Q58428767-E695D293-5EEA-4D17-9231-25F1FCF7FCB2
author name string	Xiaojiang S Chen Jonathan P Hannan Jing Hua Gabrielle J Grundy Kendra A Young Damian M Kraus Mary K Crow
rdfs:label	Characterization of human complement receptor type 2 (CR2/CD21) as a receptor for IFN-alpha: a potential role in systemic lupus erythematosus (en) Characterization of human complement receptor type 2 (nl)
skos:prefLabel	Characterization of human complement receptor type 2 (CR2/CD21) as a receptor for IFN-alpha: a potential role in systemic lupus erythematosus (en) Characterization of human complement receptor type 2 (nl)
name	Characterization of human complement receptor type 2 (CR2/CD21) as a receptor for IFN-alpha: a potential role in systemic lupus erythematosus (en) Characterization of human complement receptor type 2 (nl)
author	wds:Q58428767-38E1D7A7-A6B8-4B16-9363-59687EBF49C9 wds:Q58428767-8EEBD68A-8579-42AD-B851-507B1DE6D71F wds:Q58428767-B3C34262-D52E-4C82-BD95-76E41D4AF865 wds:Q58428767-DD3FECC8-D203-4F86-9428-F88E560FF426
author	V Michael Holers Hannah J Gould Gerda Szakonyi Rengasamy Asokan
title	wds:Q58428767-65AC1851-E96A-4520-81C7-F2D8662478D8
title	Characterization of human complement receptor type 2 (CR2/CD21) as a receptor for IFN-alpha: a potential role in systemic lupus erythematosus (en)
page(s)	wds:Q58428767-51D1C1B2-6872-4EB7-9BEE-D2FFF40B111A
page(s)	383-394
instance of	wds:Q58428767-30B07E64-AE07-4B63-827E-AFE86C5CBB71
instance of	scholarly article
main subject	wds:Q58428767-3432A5D3-2F9A-4794-BDFF-A83F4CE774A6
main subject	systemic lupus erythematosus
PubMed ID	wds:Q58428767-B26D4D46-3157-4D95-BB9C-A23DB34593EF
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16785534
PubMed ID	16785534
published in	wds:Q58428767-48E5A821-A865-4BDE-924F-7806B236CD47
published in	Journal of Immunology
issue	wds:Q58428767-20E053AA-4066-438B-B8B0-832C0D6B4B82
volume	wds:Q58428767-0B5588D4-14A1-498E-B4E5-80769EAFC975
issue	1
volume	177
DOI	wds:Q58428767-3504F263-1C35-4376-B566-F80631EE2FD3
DOI	http://dx.doi.org/10.4049/JIMMUNOL.177.1.383
DOI	10.4049/JIMMUNOL.177.1.383
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q58428767
is cites work of	Maternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies The benefit of targeted and selective inhibition of the alternative complement pathway for modulating autoimmunity and renal disease in MRL/lpr mice Epstein-Barr virus promotes interferon-alpha production by plasmacytoid dendritic cells Everyone comes from somewhere: systemic lupus erythematosus and Epstein-Barr virus induction of host interferon and humoral anti-Epstein-Barr nuclear antigen 1 immunity Complement receptor 2 is expressed in neural progenitor cells and regulates adult hippocampal neurogenesis. A molecular insight into complement evasion by the staphylococcal complement inhibitor protein family Synergistic induction of interferon α through TLR-3 and TLR-9 agonists identifies CD21 as interferon α receptor for the B cell response Canine T-zone lymphoma: unique immunophenotypic features, outcome, and population characteristics New therapeutic and diagnostic opportunities for injured tissue-specific targeting of complement inhibitors and imaging modalities Expression profiles of human interferon-alpha and interferon-lambda subtypes are ligand- and cell-dependent CR2+ marginal zone B cell production of pathogenic natural antibodies is C3 independent Human complement receptor type 1/CD35 is an Epstein-Barr Virus receptor Targeted inhibition of the complement alternative pathway with complement receptor 2 and factor H attenuates collagen antibody-induced arthritis in mice Defective B cell ontogeny and immune response in human complement receptor 2 (CR2, CD21) transgenic mice is partially recovered in the absence of C3. Human complement receptor 2 (CR2/CD21) as a receptor for DNA: implications for its roles in the immune response and the pathogenesis of systemic lupus erythematosus (SLE) Epistasis between the MHC and the RCA alpha block in primary Sjögren syndrome Type I interferon and HIV: Subtle balance between antiviral activity, immunopathogenesis and the microbiome. Analysis of host gene expression changes reveals distinct roles for the cytoplasmic domain of the Epstein-Barr virus receptor/CD21 in B-cell maturation, activation, and initiation of virus infection. Ketamine-xylazine-acepromazine compared with isoflurane for anesthesia during liver transplantation in rodents. Impaired TLR9 responses in B cells from patients with systemic lupus erythematosus. Selective HDAC6 inhibition decreases early stage of lupus nephritis by down-regulating both innate and adaptive immune responses. A novel C3d-containing oligomeric vaccine provides insight into the viability of testing human C3d-based vaccines in mice. Molecular basis of the interaction between complement receptor type 2 (CR2/CD21) and Epstein-Barr virus glycoprotein gp350. Prioritization of cancer-related genomic variants by SNP association network Mapping of the C3d ligand binding site on complement receptor 2 (CR2/CD21) using nuclear magnetic resonance and chemical shift analysis Biophysical investigations of complement receptor 2 (CD21 and CR2)-ligand interactions reveal amino acid contacts unique to each receptor-ligand pair Association of complement receptor 2 polymorphisms with innate resistance to HIV-1 infection Differential regulation of monocyte cytokine release by αV and β(2) integrins that bind CD23.
is cites work of	wds:Q34629175-FA1FCE4D-04E5-4387-84BA-11F632A1CB6F wds:Q34507790-84F4D4E1-976C-43D1-9CD1-023F8322C392 wds:Q36975018-D80F3DD3-0DBB-43C6-964C-9EA7BEB78FC2 wds:Q41910146-9181C1C2-9C4B-4433-B3B6-4CB9111BCACD wds:Q41063107-1EAB6CA3-C1ED-48AB-A5E4-0EA53661133E wds:Q52342680-55AE99EA-06B5-4BD4-B6B3-A747EBA439B0 wds:Q24296010-DDB2BF6E-1A43-45B9-B812-8243DCAB15A4 wds:Q24632150-AA5739F8-F6E3-461A-BD94-83015EFD0A13 wds:Q33896074-405D72A9-EAD5-4E74-994F-097ADD4E5A2C wds:Q41556124-EEBA9CD6-AAA7-4CEE-AA35-76CD4E50C3CD wds:Q34597080-EA2D0FD0-6EBE-4153-9CA4-AFAC0039C702 wds:Q33687307-D49F95F1-A933-48B6-B767-3A8638AF3AAE

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 169 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software